Propentofylline News
New Computer Analysis Detects Early Alzheimer's Disease
A new computer-based technique may help find early cell damage in people who have Alzheimer's disease (AD).
Behavioral Manifestations of Alzheimer's Disease
Alzheimer’s Dementia has a combination of cognitive and behavioral manifestations.
Aventis Pharma Discontinues Development of Propentofylline
Aventis Pharma (Frankfurt, Germany) the pharmaceutical company of Aventis S.A., has announced that it is discontinuing development of propentofylline as a possible treatment for Alzheimer disease.
Propentofylline for Alzheimer's, Dementia
Patients with Alzheimer's disease and vascular dementia responded well to propentofylline, a drug that may become available in the United States within the next few years.
Two New Therapies 'Buy More Quality Time' for Alzheimer's Patients
Two new drugs, one already approved by the FDA, are showing promise for people suffering from Alzheimer's disease. Researchers presented the details at a recent meeting of the American Neurological Association in Seattle.